Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  ObesityPublic HealthIssue 729

AACE Announces a New Medically-Actionable Diagnosis of Obesity

An advanced framework for a new diagnostic approach to obesity was announced last week by the American Association of Clinical Endocrinologists (AACE) at their 23rd Scientific and Clinical Congress.... 

Advertisement

An emergent concept from the Consensus Conference on Obesity, convened by AACE and the American College of Endocrinology (ACE) in March 2014, was that the current diagnostic definition of obesity, which relied on an anthropomorphic measure of body mass index (BMI), needed to be updated. BMI alone does not indicate how weight gain might be affecting the health of individual patients, and multiple stakeholders at the Consensus Conference saw this as a major obstacle to concerted action in combatting obesity.

The new obesity definition and diagnostic strategy is actionable, medically-meaningful and adds value to the health-promoting effects of weight loss.

Dr. W. Timothy Garvey, Chair of the AACE/ACE Consensus Conference on Obesity and Obesity Scientific Committee and author of the AACE/ACE Obesity Consensus Statement, added that, "This approach addresses a problem of diagnostic uncertainty and is the first step in removing the impediment for concerted and comprehensive action among health care professionals, health care systems, regulators, payers, and employers."

In 2011, AACE/ACE declared obesity as a chronic disease as did the American Medical Association in June 2013.

The new approach does not simply depend upon BMI alone, but also the impact of weight gain on health. A four-step approach is recommended for all patients: screening using BMI with adjustments for ethnic differences, clinical evaluation for the presence of obesity-related complications using a checklist, staging for the severity of complications using complication-specific criteria, and selection of prevention and/or intervention strategies targeting specific complications as guided by the AACE/ACE obesity management algorithm.

The next steps will be to obtain broad input and recommendations regarding the framework for the new diagnostic approach from participants at the Consensus Conference on Obesity. The goal is to assure broad-based acceptance, translation, and implementation of the diagnosis that will support concerted action around a rational and comprehensive plan to prevent and treat obesity.

Presented at the 2015 Meeting of the American Association of Clinical Endocrinologists. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 16 May, 2014 and appeared in  ObesityPublic HealthIssue 729

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

2015 Most Popular Articles:

Coffee Consumption Proves Potential in Reducing Type 2 Diabetes Risk
Posted August 07, 2015
Impaired Glucose Uptake in the Brain May Increase Alzheimer's Disease Risk
Posted August 07, 2015
Ketoacidosis Not as Great as Thought in Diabetes Patients Taking Invokana
Posted August 13, 2015
First Non-Surgical Weight Loss Procedure for Mild-to-Moderate Obesity
Posted August 07, 2015
Impact of Switching Insulin Glargine to Insulin Detemir in T2 Patients
Posted August 14, 2015
SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy
Posted August 14, 2015
GLP-1 Agonist Semaglutide Completes Phase III Trial with Positive Results
Posted August 07, 2015
Soybean Oil Causes More Obesity and Diabetes Than Fructose
Posted August 20, 2015
Diabetes Combination Drug LixiLan Meets Main Target in Late Stage Trial
Posted August 07, 2015
Two New Possible Methods for Diagnosing and Monitoring Diabetes
Posted August 07, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Warren Joseph, DPM, FIDSA

Category: Wound Care
Credits: .75